Advisory panel recommends allowing compounding pharmacies to produce popular but unproven BPC-157 an...
In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
Advisory panel recommends allowing compounding pharmacies to produce popular but unproven BPC-157 and KPV peptides.
Author: STAT
Read Original Article